CCQ25 Tablet

CCQ25 Tablet is an ovulation stimulant medication used to treat infertility in women who are not ovulating (producing an egg) properly or have an irregular or no menstrual cycle. Ovulation issues are a common cause of female infertility.

CCQ25 Tablet is a combination of Clomifene Citrate (oestrogen agonist) and Ubidecarenone (nutritional supplements). Clomifene Citrate boosts the production of hormones involved in the ovulation process. Ubidecarenone is an antioxidant that protects the body from harm caused by chemicals (free radicals) that cause infertility. As a result, CCQ25 Tablet effectively addresses female infertility.

You should take this medicine as prescribed by your doctor. The common side-effects of CCQ25 Tablet are flushing (reddening of the skin, especially the face), headache, Insomnia, tiredness, dizziness, breast pain or tenderness, heavy periods, or bleeding between periods. Tell your doctor if any of these side effects persist or worsen.

Do not take CCQ25 Tablet if you are allergic to Clomifene Citrate or Ubidecarenone or any other ingredients present in it, have liver disease, unexplained and unusual menstrual bleeding, have a type of cancer worse by hormones, or have an ovarian cyst. It is not recommended to use in pregnant women. So, taking a pregnancy test before using this medicine is advised. It is also not recommended for use in children, adolescents, men, and post-menopausal women. Inform your doctor if you are breastfeeding, as this medicine may affect the amount of breast milk produced. Before taking this medicine, let your doctor know if you are taking any other prescription, non-prescription medicines, or herbal products.

CCQ25 Tablet is a combination of Clomifene Citrate (oestrogen agonist) and Ubidecarenone (nutritional supplements). Clomifene Citrate boosts the production of hormones involved in the ovulation process. Ubidecarenone is an antioxidant that protects the body from harm caused by chemicals (free radicals) that cause infertility. Also, Ubidecarenone supplementation results in a better response to ovulation induction and a lower risk of foetal aneuploidy. As a result, CCQ25 Tablet effectively addresses female infertility.

If you are allergic or hypersensitive to Clomifene Citrate, Ubidecarenone, or any other ingredients in CCQ25 Tablet , do not take it. Inform your doctor if you are experiencing early menopause, have been diagnosed as infertile, have stopped menstruating due to being underweight, have previously been diagnosed with fits or seizures (fits), uterine fibroids (non-cancerous tumours in the womb), polycystic ovaries (presence of small cysts on the enlarged ovaries), swollen ovaries, or hypertriglyceridemia (increased fat levels in the body), Before prescribing this medication, your doctor may perform additional tests to rule out other causes of infertility. Because CCQ25 Tablet contains lactose and sucrose, consult your doctor if you are sensitive to sugar. Do not begin taking a new medication without first consulting your doctor. To avoid potential interactions, inform your doctor about any prescription and non-prescription medications you are taking, including other vitamins, before beginning CCQ25 Tablet .

CCQ25 Tablet may cause multiple pregnancies (pregnant with more than one child at the same time) or ectopic pregnancy (growing foetus outside the womb). These conditions may also occur if you are not taking this medicine. However, discuss with your doctor the possible risks before taking CCQ25 Tablet .